SMOLINSKI; Michael P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SMOLINSKI; Michael P..The latest application filed is for "acetamido-phenylbenzamide derivatives and methods of using the same".

Company Profile

12.6.15

SMOLINSKI; Michael P. - Amherst NY
Smolinski; Michael P. - Port St. Lucie FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Acetamido-phenylbenzamide Derivatives And Methods Of Using The Same App 20220106301 - URGAONKAR; Sameer ; et al.	2022-04-07
Acetamido-phenyltetrazole Derivatives And Methods Of Using The Same App 20220106312 - URGAONKAR; Sameer ; et al.	2022-04-07
Solid Forms Of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide App 20220098152 - SMOLINSKI; Michael P.	2022-03-31
Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n- benzylacetamide Grant 11,230,527 - Smolinski January 25, 2	2022-01-25
Biaryl Piperidine Amide Compounds And Methods Of Use Thereof App 20210347763 - SMOLINSKI; Michael P. ; et al.	2021-11-11
Biaryl Compositions And Methods For Modulating A Kinase Cascade App 20210196724 - SMOLINSKI; Michael P. ; et al.	2021-07-01
Biaryl compositions and methods for modulating a kinase cascade Grant 10,973,828 - Smolinski , et al. April 13, 2	2021-04-13
Biaryl piperidine amide compounds and methods of use thereof Grant 10,899,747 - Smolinski , et al. January 26, 2	2021-01-26
Solid Forms Of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide App 20200255380 - Kind Code	2020-08-13
Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide Grant 10,669,236 - Smolinski	2020-06-02
Biaryl Piperidine Amide Compounds And Methods Of Use Thereof App 20200071305 - SMOLINSKI; Michael P. ; et al.	2020-03-05
Biaryl piperidine amide compounds and methods of use thereof Grant 10,450,303 - Smolinski , et al. Oc	2019-10-22
THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF ANGIOSARCOMA App 20190314361 - KWAN; Min-Fun Rudolf ; et al.	2019-10-17
Biaryl Compositions And Methods For Modulating A Kinase Cascade App 20190125754 - SMOLINSKI; Michael P. ; et al.	2019-05-02
Solid Forms Of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide App 20190071402 - SMOLINSKI; Michael P.	2019-03-07
Biaryl compositions and methods for modulating a kinase cascade Grant 10,213,435 - Smolinski , et al. Feb	2019-02-26
Biaryl Piperidine Amide Compounds And Methods Of Use Thereof App 20180265499 - SMOLINSKI; Michael P. ; et al.	2018-09-20
Biaryl Compositions And Methods For Modulating A Kinase Cascade App 20180042934 - SMOLINSKI; Michael P. ; et al.	2018-02-15
Benzopyrans And Analogs As Rho Kinase Inhibitors App 20110150833 - Feng; Yangbo ; et al.	2011-06-23
Benzimidazoles And Analogs As Rho Kinase Inhibitors App 20110052562 - Feng; Yangbo ; et al.	2011-03-03
Anilides And Analogs As Rho Kinase Inhibitors App 20110038835 - Feng; Yangbo ; et al.	2011-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.